Integrating novel agents into multiple myeloma treatment – current status in Switzerland and treatment recommendations

Christian Taverna; Mario Bargetzi; Daniel Betticher; Jürg Gmür; Michael Gregor; Dominik Heim; Urs Hess; Nicolas Ketterer; Erika Lerch; Thomas Matthes; Ulrich Mey; Thomas Pabst; Christoph Renner

doi:10.4414/smw.2010.12989

Review article: Biomedical intelligence

Vol. 140 No. 1516 (2010)

Integrating novel agents into multiple myeloma treatment – current status in Switzerland and treatment recommendations

Christian Taverna
Mario Bargetzi
Daniel Betticher
Jürg Gmür
Michael Gregor
Dominik Heim
Urs Hess
Nicolas Ketterer
Erika Lerch
Thomas Matthes
Ulrich Mey
Thomas Pabst
Christoph Renner

Fulltext PDF

DOI: https://doi.org/10.4414/smw.2010.12989
Cite this as:: Swiss Med Wkly. 2010;140:1-21
Published: 24.04.2010

How to Cite

1.

Taverna C, Bargetzi M, Betticher D, Gmür J, Gregor M, Heim D, Hess U, Ketterer N, Lerch E, Matthes T, Mey U, Pabst T, Renner C. Integrating novel agents into multiple myeloma treatment – current status in Switzerland and treatment recommendations. Swiss Med Wkly [Internet]. 2010 Apr. 24 [cited 2024 Nov. 28];140(1516):1-21. Available from: https://smw.ch/index.php/smw/article/view/1111

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Panagiotis Samaras, Dimitrios Zardavas, Ulf Petrausch, Elefteri Marcel Buset, Sarah R. Haile, Hanspeter Honegger, Raffaele Daniele Siciliano, Urs Schanz, Axel Mischo, Niklaus G. Schäfer, Christian Taverna, Alexander Knuth, Rolf Stahel, Christoph Renner, Frank Stenner-Liewen, Prognostic factors for survival in lymphoma patients after autologous stem cell transplantation , Swiss Medical Weekly: Vol. 143 No. 1920 (2013)
Christian Taverna, Jérôme Voegeli, Andreas Trojan, Robert A Olie, Albert von Rohr, Effective response with bortezomib retreatment in relapsed multiple myeloma , Swiss Medical Weekly: Vol. 142 No. 1718 (2012)

<< < 1 2 3